Odegård R A, Vatten L J, Nilsen S T, Salvesen K A, Austgulen R
Institute of Cancer Research and Molecular Biology, University Medical Center, Trondheim, Norway.
Obstet Gynecol. 2000 Dec;96(6):950-5.
To determine if the influence of preeclampsia on birth size varies with clinical manifestations of the disease, and to evaluate whether maternal factors, such as smoking, modify the effect of preeclampsia on fetal growth.
Among 12,804 deliveries in a population of approximately 239,000 over a 3-year period, 307 live singleton infants were born after preeclamptic pregnancies. We compared those with a sample of 619 control infants. Preeclampsia was defined as increased diastolic blood pressure (BP) (increase of at least 25 mmHg to at least 90 mmHg) and proteinuria after 20 weeks' gestation. Clinical manifestations were classified according to BP and proteinuria into subgroups of mild, moderate, or severe (including cases with eclampsia and hemolysis, elevated liver enzymes, low platelets [HELLP] syndrome) preeclampsia, and according to gestational age at onset, as early or late preeclampsia. Birth size was expressed as the ratio between observed and expected birth weights, and infants smaller than two standard deviations from expected birth weights were classified as small for gestational age (SGA).
Preeclampsia was associated with a 5% (95% confidence interval [CI] 3%, 6%) reduction in birth weight. In severe preeclampsia, the reduction was 12% (9%, 15%), and in early-onset disease, birth weight was 23% (18%, 29%) lower than expected. The risk of SGA was four times higher (relative risk [RR] = 4.2; 95% CI 2.2, 8.0) in infants born after preeclampsia than in control pregnancies. Among nulliparas, preeclampsia was associated with a nearly threefold higher risk of SGA (RR = 2.8; 1.2, 5.9), and among paras, the risk of SGA was particularly high after recurrent preeclampsia (RR = 12.3; 3.9, 39.2). In relation to preeclampsia and maternal smoking, the results indicated that each factor might contribute to reduced growth in an additive manner.
Severe and early-onset preeclampsia were associated with significant fetal growth restriction. The risk of having an SGA infant was dramatically higher in women with recurrent preeclampsia. Birth weight reduction related to maternal smoking appeared to be added to that caused by preeclampsia, suggesting that there is no synergy between smoking and preeclampsia on growth restriction.
确定子痫前期对出生体重的影响是否因该疾病的临床表现而异,并评估诸如吸烟等母体因素是否会改变子痫前期对胎儿生长的影响。
在三年期间对约239,000人的人群中的12,804例分娩进行研究,其中307例单胎活产婴儿是子痫前期妊娠后出生的。我们将这些婴儿与619例对照婴儿的样本进行比较。子痫前期定义为妊娠20周后舒张压升高(至少升高25 mmHg至至少90 mmHg)和蛋白尿。根据血压和蛋白尿将临床表现分为轻度、中度或重度(包括子痫和溶血、肝酶升高、血小板减少[HELLP]综合征病例)子痫前期亚组,并根据发病时的孕周分为早发型或晚发型子痫前期。出生体重以观察到的出生体重与预期出生体重之比表示,出生体重低于预期出生体重两个标准差的婴儿被分类为小于胎龄儿(SGA)。
子痫前期与出生体重降低5%(95%置信区间[CI] 3%,6%)相关。在重度子痫前期中,出生体重降低12%(9%,15%),在早发型疾病中,出生体重比预期低23%(18%,29%)。子痫前期后出生的婴儿患SGA的风险比对照妊娠高四倍(相对风险[RR] = 4.2;95% CI 2.2,8.0)。在初产妇中,子痫前期与SGA风险高近三倍相关(RR = 2.8;1.2,5.9),在经产妇中,复发性子痫前期后患SGA的风险风险特别高(RR = 12.3;3.9,39.2)。关于子痫前期与母体吸烟,结果表明每个因素可能以累加方式导致生长受限。
重度和早发型子痫前期与显著的胎儿生长受限相关。复发性子痫前期的女性生出SGA婴儿的风险显著更高。与母体吸烟相关的出生体重降低似乎叠加在子痫前期导致的降低之上,这表明吸烟与子痫前期在生长受限方面不存在协同作用。